explore -WSS

explore

author：fashion 2025-10-02 21:06:39 - browse：22

Illustrated scene from Headspace XR Clubhouse. -- biotech coverage from STAT — Headspace XR, developed with funding from Meta, guides users through meditation and other activities, such as a Tai Chi-inspired game. Courtesy Headspace

Headspace, which has built a growing digital health business around mindfulness, is joining forces with Meta to launch a meditation app for Quest, the social media giant’s virtual reality headset.

Called Headspace XR, the newly launched VR app — developed with funding from Meta — guides users through meditation and other activities meant to encourage mental well-being, like a tai chi-inspired movement game in which users wave their arms around to capture colorful energy bubbles. Headspace leaders said the app, an attempt to engage with younger people, will help the company study the potential for virtual reality to improve mental health.

“Success is reading a headline that says ‘Gen Z’s flooding Headspace XR and feeling less alone,’” Sara Cohen, Headspace’s vice president of content creation told STAT. “That the generation of people that we’ve designed this for are truly feeling the positive benefits.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： How Vertex's cystic fibrosis drug is changing patients' lives

WSS

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Medical mystery: When a cough is not just a cough

Biotech stock slump in 2023: awaiting the turnaround

The Readout: Gilead, Bernie Sanders, and other pharma news

BioAge raises $170M for combination therapy with Zepbound

What we’ve learned from the Aduhelm mess

focus

explore

hotspot

Medicare proposal to cover medical devices draws a mixed reaction

It's been 20 years since Dolly the sheep. Where's my clone?

FDA approval of Sarepta Duchenne genetic therapy gives me hope

BioAge raises $170M for combination therapy with Zepbound

Medicare details structure of new drug price negotiation program

Biotech lab space demand falls sharply

After affirmative action ruling, medical educators look to 'holistic review'

Second xenotransplant done with gene

State Dept. review finds Biden bears some blame for Afghanistan failures

Biogen Alzheimer’s drug launch off to slow start

hotspot

Medical mystery: When a cough is not just a cough

Lasker Awards 2023: Winners in biomedical research

Biotech stock slump in 2023: awaiting the turnaround

Biden report: The neurospychology of memory and aging

Emergency workers more likely to restrain Black patients: study

Biotech stock slump in 2023: awaiting the turnaround

Wikipedia

entertainment

knowledge

entertainment